# Treatment options for Sjögren's syndrome
Treatment of Sjögren's syndrome is aimed at relieving symptoms, reducing inflammation activity and preventing harmful effects on organs. There is no cure; the goals are stabilization of symptoms and preservation of quality of life. Treatment is tailored to which symptoms are dominant and how active the underlying autoimmune process is.
Symptomatic treatment for dry eyes and mouth
Artificial tears and eye lubricants ProveniIncluded in official guidelines, or approved by EMA or FDA
Artificial tears in drop form or eye ointment are the first-line treatment for dry eyes. These preparations replace moisture secretion and protect the eye surface. They reduce irritation and prevent damage to the cornea. Many patients use these several times a day. Heavier formulations (gels, ointments) are applied mainly in the evening because they cloud vision. Side effects are rare; sometimes irritation occurs from preservatives in some drops.
Plugs for tear ducts ProveniIncluded in official guidelines, or approved by EMA or FDA
Small stop devices can be inserted into the tear drainage ducts to keep natural tears on the eye longer. This is especially considered if artificial tears provide insufficient relief. The procedure is simple and reversible. Residual sensations or displacement of the plug may occur; removal restores the situation.
Saliva replacement and stimulation agents ProveniIncluded in official guidelines, or approved by EMA or FDA
For dry mouth, saturated rinses or gels are available that replicate saliva. These provide moisture intake and protect teeth and oral mucosa. Additionally, certain agents can stimulate salivary glands to secrete more, provided some gland function remains. Side effects of stimulants can include stomach and intestinal complaints. Regular tooth brushing, flossing and fluoride treatments are important because of increased cavity risk.
Anti-inflammatory and immunomodulatory treatment
Corticosteroids ProveniIncluded in official guidelines, or approved by EMA or FDA
Low doses of corticosteroids are used for systemic inflammatory symptoms, for example swollen salivary glands, arthralgias or mild lung involvement. They work by suppressing immune activity. Long-term use can cause side effects such as bone loss, increased infection risk and weight gain; therefore they are used in the lowest possible doses and for as short a time as possible.
Antimalarial (hydroxychloroquine) ProveniIncluded in official guidelines, or approved by EMA or FDA
This agent is widely used as first-line immunomodulatory treatment for moderate systemic activity. It works presumably by inhibiting certain immune pathways and is well tolerated. It works slowly (weeks to months). Rare side effects concern eye and muscle complaints; regular eye checks are therefore recommended.
TNF-alpha inhibitors ProveniIncluded in official guidelines, or approved by EMA or FDA
Medications that block tumor necrosis factor-alpha (TNF-α) are used for more severe arthritis or systemic manifestations. They work by eliminating an important inflammatory cytokine. Side effects include increased infection risks and in rare cases autoimmune reactions.
B-cell inhibitors ProveniIncluded in official guidelines, or approved by EMA or FDA
B cells play a central role in Sjögren's syndrome. Rituximab (anti-CD20) has been investigated and used in study settings to suppress B-cell activity. This agent is based on the same mechanism of action as in other autoimmune diseases. Side effects can include infections and fluid phase reactions.
Abatacept and belatacept ResearchediPositive results in clinical studies, not yet standard treatment
These agents inhibit T-cell activation by blocking co-stimulation signals. Recent reviews show positive results in Sjögren's syndrome and related autoimmune diseases. They are in the investigational phase for this indication. Possible side effects are similar to other immunosuppressants.
Treatment of lung involvement
Corticosteroids and immunosuppressants ProveniIncluded in official guidelines, or approved by EMA or FDA
When the lungs are involved (interstitial lung disease), corticosteroids are given at higher doses, possibly combined with immunosuppressive agents such as azathioprine or mycophenolate mofetil. They are intended to slow lung fibrosis. Monitoring is done with lung function tests and imaging.
Nicotinamide adenine dinucleotide (NAD) precursors and interferon-directed management ResearchediPositive results in clinical studies, not yet standard treatment
Recent research points to interferon activation as a driving force in certain Sjögren features. Interferon inhibitors and targeted anti-interferon approaches are in the research phase. This approach is not yet routinely applied.
Treatment of Fatigue
Multidisciplinary management ProveniIncluded in official guidelines, or approved by EMA or FDA
Fatigue is often the most disabling symptom, but does not always follow inflammation levels. Treatment includes exercise adapted to capacity, sleep hygiene, psychological support and treatment of comorbid conditions (thyroid problems, depression). Pharmacologically there are few specific agents; focus is on lifestyle and psychosocial factors.
Treatment of kidney complications
Corticosteroids and immunosuppressants ProveniIncluded in official guidelines, or approved by EMA or FDA
When the kidneys are involved (tubular function loss or interstitial nephritis), corticosteroids are used with immunosuppressants. Treatment aims at inflammation suppression before permanent kidney damage occurs.
Treatment of neurological complications
Corticosteroids, intravenous immunoglobulin (IVIG) and plasma exchange ProveniIncluded in official guidelines, or approved by EMA or FDA
Neurological manifestations (myelitis, neuropathy, cerebellar syndrome) require intensive immunosuppression. IVIG and plasma exchange can treat acute complications. Corticosteroids are first line. These complications are rare but serious.
Additional monitoring styles
Regular check-ups ProveniIncluded in official guidelines, or approved by EMA or FDA
Regardless of treatment, patients are regularly monitored for:
- Lung function and imaging (if at risk for lung disease)
- Kidney function (creatinine, urine protein)
- Blood values (blood cell counts, liver values)
- Eye status (especially with hydroxychloroquine use)
This ensures that harmful effects are noticed early and treatment can be adjusted.
---
_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._